Research Article

Synergistic Anticancer Effects of Low-Frequency Magnetic Field and Doxorubicin on Glioblastoma Cell Line

Volume: 4 Number: 1 July 13, 2025

Synergistic Anticancer Effects of Low-Frequency Magnetic Field and Doxorubicin on Glioblastoma Cell Line

Abstract

Glioblastoma (GBM) is one of the most aggressive primary brain tumors of the central nervous system, with a limited median survival of approximately 15 months despite current treatment options. In this study, the effects of a low-frequency magnetic field (LF-MF) in combination with the chemotherapeutic agent doxorubicin (DOX) on the glioblastoma cell line (U87MG) were investigated. In the experimental design, U87MG cells were exposed to LF-MF at intensity of 1 mT and treated with different concentrations of DOX (5 µg/ml and 10 µg/ml). Cell viability was assessed using the MTT assay, nuclear morphological changes were analyzed with Hoechst 33258 staining, and apoptotic and necrotic cell percentages were determined by flow cytometry. The results showed that DOX alone reduced cell viability in a dose-dependent manner (IC₅₀= 3.22 µg/ml). However, in the presence of LF-MF, DOX's cytotoxic effect increased, leading to a decrease in the IC₅₀ value to 2.18 µg/ml. Flow cytometry analyses revealed that while 5 µg/ml and 10 µg/ml DOX alone increased apoptotic cell percentages to 23.4% and 38.7%, respectively, these rates increased to 37.2% and 52.5% when combined with LF-MF. Compared to the control group, LF-MF did not alter toxicity in the healthy fibroblast cell line (HDFa) and had no additional effect on DOX-induced cell death. However, in glioblastoma cells, LF-MF-supported DOX treatment significantly enhanced cell death, suggesting that LF-MF may improve DOX efficacy by increasing cell membrane permeability and reactive oxygen species (ROS) production. This study demonstrates that the combination of LF-MF and DOX exerts a synergistic effect on glioblastoma cells by enhancing cell death. LF-MF-assisted chemotherapy strategies could be a potential alternative in glioblastoma treatment, but further molecular and biochemical studies are needed to elucidate the underlying mechanisms.

Keywords

Glioblastoma , Low-Frequency Magnetic Field , Doxorubicin , Apoptosis , Chemotherapy , Cell Viability

References

  1. 1. Türkiye Klinikleri. (2018). Biyofilm nedir? Türkiye Klinikleri. Erişim tarihi: 9 Aralık 2024, https://www.turkiyeklinikleri.com/article/en-what-is-biofilm--83796.html
  2. 2. Kartal, M., & Ekinci, M. (2021). Biyofilm yapısı ve önlenmesi. Akademik Gıda, Erişim tarihi: 9 Aralık 2024, https://dergipark.org.tr/en/pub/akademik-gida/article/1011231 3. Jefferson, K. K. (2004). What drives bacteria to produce a biofilm? FEMS Microbiology Letters, 236(2), 163–173. https://doi.org/10.1016/j.femsle.2004.06.005
  3. 4. Erkihun, M., Asmare, Z., Endalamew, K., Getie, B., Kiros, T., & Berhan, A. (2024). Medical scope of biofilm and quorum sensing during biofilm formation: Systematic review. Bacteria, 3(3), 118–135. https://doi.org/10.3390/bacteria3030008
  4. 5. Mirzaei, R., Abdi, M., & Gholami, H. (2020). The host metabolism following bacterial biofilm: What is the mechanism of action? Reviews and Research in Medical Microbiology, 31(4), 175–182. https://doi.org/10.1097/MRM.0000000000000216
  5. 6. Tarım ve Yaban Hayatı Bilimleri Dergisi. (2019). Güneydoğu Anadolu Bölgesinin farklı lokasyonlarından toplanan Boynuzlu Geven (Astragalus hamosus L.) otunun bazı kalite özelliklerinin belirlenmesi. Uluslararası Tarım ve Yaban Hayatı Bilimleri Dergisi, 5(2), 346–354. https://doi.org/10.24180/IJAWS.594960
  6. 7. Ekiz, G., Yılmaz, S., Yusufoglu, H., Kırmızıbayrak, P. B., & Bedir, E. (2019). Microbial transformation of cycloastragenol and astragenol by endophytic fungi isolated from Astragalus species. Journal of Natural Products, 82(11), 2979–2985. https://doi.org/10.1021/acs.jnatprod.9b00336
  7. 8. Li, X., et al. (2014). A review of recent research progress on the Astragalus genus. Molecules, 19(11), 18850–18880. https://doi.org/10.3390/molecules191118850
  8. 9. Abd Elkader, H. T. A. E., Essawy, A. E., & Al-Shami, A. S. (2022). Astragalus species: Phytochemistry, biological actions and molecular mechanisms underlying their potential neuroprotective effects on neurological diseases. Phytochemistry, 202, 113293. https://doi.org/10.1016/j.phytochem.2022.113293
  9. 10. Lavecchia, T., Rea, G., Antonacci, A., & Giardi, M. T. (2012). Healthy and adverse effects of plant-derived functional metabolites: The need of revealing their content and bioactivity in a complex food matrix. Critical Reviews in Food Science and Nutrition, 53(2), 198. https://doi.org/10.1080/10408398.2010.520829
  10. 11. Türkiye Florasında Yer Alan Endemik Astragalus Taksonları (Endemic Astragalus Taxa Found in Flora of Turkey). (2025, April 4). Erişim adresi: https://www.google.com/search?q=T%C3%BCrkiye+Floras%C4%B1nda+Yer+Alan+Endemik+Astragalus+Taksonlar%C4%B1+(...)
APA
Ergene, H., Aydemir, M., Arslan, M. E., Berber, G., Men, D. E., Karataş, H., Arslan, E., Aksakal, C., & Türkez, H. (2025). Synergistic Anticancer Effects of Low-Frequency Magnetic Field and Doxorubicin on Glioblastoma Cell Line. Eurasian Journal of Molecular and Biochemical Sciences, 4(1), 25-36. https://izlik.org/JA77UZ69JK